Tilray Inc
Change company Symbol lookup
Select an option...
TLRY Tilray Inc
GTX Garrett Motion Inc
ADOC Edoc Acquisition Corp
GM General Motors Co
PKKFF Tenet Fintech Group Inc
NETLF NetLink NBN Trust
VMI Valmont Industries Inc
FF FutureFuel Corp
GLPI Gaming and Leisure Properties Inc
EQNR Equinor ASA
Go

Health Care : Pharmaceuticals | Small Cap Growth
Based in Canada
Company profile

Tilray, Inc. is a global cannabis-lifestyle consumer packaged goods company. The Company operates through five segments cannabis business, distribution business, beverage alcohol business and wellness business. The cannabis business segment is engaged in the cultivation, production, distribution and sale of both medical and adult-use cannabis products. The distribution business segment is engaged in the purchase and resale of pharmaceutical and wellness products to customers. The beverage alcohol business segment is focused on the production, distribution and sale of beverage alcohol products. The wellness business segment offers production, marketing and distribution of hemp-based food and other wellness products. The Company operates in Canada, the United States, Europe, Australia and Latin America.

Closing Price
$8.95
Day's Change
-0.59 (-6.18%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.55
Day's Low
8.69
Volume
(Above Average)
Volume:
26,001,700

10-day average volume:
23,198,905
26,001,700

Bristol Myers Squibb Co. Stock Falls Thursday, Underperforms Market

4:41 pm ET October 7, 2021 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Bristol Myers Squibb Co. (BMY) sank 0.30% to $59.01 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.83% to 4,399.76 and the Dow Jones Industrial Average rising 0.98% to 34,754.94. The stock's fall snapped a two-day winning streak. Bristol Myers Squibb Co. closed $10.74 short of its 52-week high ($69.75), which the company achieved on August 23rd.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.89% to $161.34, Merck & Co. Inc. (MRK) rose 1.59% to $81.94, and Pfizer Inc. (PFE) rose 1.71% to $42.74. Trading volume (13.7 M) eclipsed its 50-day average volume of 8.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled October 7, 2021.

-MarketWatch Automation

	

(END) Dow Jones Newswires

October 07, 2021 16:41 ET (20:41 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.